Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras

N A Cacalano1, D Sanden, J A Johnston

  • 1DNAX Research Institute, 901 California Avenue, Palo Alto, California 94304, USA.

Insights

Suppressors of cytokine signalling (SOCS) proteins regulate cell responses. Tyrosine phosphorylation of SOCS-3 surprisingly promotes cell survival and proliferation via the Ras pathway, despite inhibiting other growth factor signals.

Area of Science:

  • Cellular signaling
  • Molecular biology
  • Immunology

Background:

  • Suppressors of cytokine signalling (SOCS) proteins, including SOCS-3, are immediate early genes involved in negative feedback regulation of cytokine signaling pathways.
  • SOCS proteins inhibit the activation of signal transducer and activator of transcription (STAT) factors, thereby dampening cellular responses to cytokines.
  • Understanding the precise mechanisms by which SOCS proteins modulate signaling pathways is crucial for comprehending cellular growth and survival regulation.

Purpose of the Study:

  • To investigate the role of tyrosine phosphorylation of SOCS-3 in response to various growth factors.
  • To elucidate the interaction of phosphorylated SOCS-3 with downstream signaling molecules, specifically p120 RasGAP.
  • To determine the impact of SOCS-3 phosphorylation status on the activation of STAT and extracellular-signal-regulated kinase (ERK) pathways and subsequent cell proliferation.

Main Methods:

  • Western blotting to detect tyrosine phosphorylation of SOCS-3 in response to interleukin-2 (IL-2), erythropoietin (EPO), epidermal growth factor (EGF), and platelet-derived growth factor (PDGF).
  • Co-immunoprecipitation assays to assess the interaction between phosphorylated SOCS-3 and p120 RasGAP.
  • Analysis of STAT5 and ERK activation using phospho-specific antibodies after cytokine stimulation in cells expressing wild-type or tyrosine mutant SOCS-3.
  • Cell proliferation assays to evaluate the effect of SOCS-3 phosphorylation on IL-2, EPO, and PDGF-induced proliferation.

Main Results:

  • SOCS-3 undergoes strong tyrosine phosphorylation upon stimulation with IL-2, EPO, EGF, and PDGF.
  • Phosphorylation at residues 204 and 221 of SOCS-3 facilitates interaction with p120 RasGAP.
  • Phosphorylated SOCS-3 inhibits STAT5 activation but maintains ERK activation via RasGAP binding following IL-2 stimulation.
  • A tyrosine mutant of SOCS-3 blocked STAT phosphorylation and also strongly inhibited IL-2-, EPO-, and PDGF-induced ERK activation and cell proliferation.

Conclusions:

  • Tyrosine phosphorylation of SOCS-3 plays a dual role: inhibiting STAT signaling while promoting Ras/ERK pathway activation.
  • The interaction of phosphorylated SOCS-3 with RasGAP is critical for maintaining ERK activation and promoting cell proliferation.
  • Despite the general inhibitory role of SOCS proteins, tyrosine phosphorylation of SOCS-3 paradoxically supports cell survival and proliferation through the Ras pathway.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...